"/> Tocris Bioscience™ JNJ 1013 | B-LABO France

Tocris Bioscience™ JNJ 1013

Réf. : BL-RE-124749Réf. fabricant : 18084262 5 mg
283,31 € HT

Interleukin 1 Receptor Associated Kinase 1 (IRAK1) PROTAC™

Nom chimique ou matériau
N-(4-(4-(2-(((S)-1-((2S,4R)-4-Hydroxy-2-(((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)amino)-2-oxoethoxy)piperidin-1-yl)-2-methoxyphenyl)-6-(1H-pyrazol-5-yl)picolinamide
CAS
2597343-08-1
Quantité
5 mg
Cible
Active Degraders
Formule moléculaire
C46H55N9O7S
Marque
Tocris Bioscience

JNJ 1013 is a potent interleukin 1 receptor associated kinase 1 (IRAK1) PROTAC™ Degrader (DC50 = 3 nM; Dmax = 96%). In ABC DLBCL cell lines with MyD88 L265P mutation, JNJ 1013 potently inhibits IRAK1 downstream signaling pathways, induces apoptosis, and shows strong anti-proliferative effects.

PROTAC™ is a registered trademark of Arvinas Operations, Inc., and is used under license

.

Caractéristiques techniques

MarqueTocris Bioscience
Réf. B-LABOBL-RE-124749
Réf. fabricant18084262
Nom chimique ou matériauN-(4-(4-(2-(((S)-1-((2S,4R)-4-Hydroxy-2-(((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)amino)-2-oxoethoxy)piperidin-1-yl)-2-methoxyphenyl)-6-(1H-pyrazol-5-yl)picolinamide
CAS2597343-08-1
Quantité5 mg
CibleActive Degraders
Formule moléculaireC<sub>46</sub>H<sub>55</sub>N<sub>9</sub>O<sub>7</sub>S
Pureté98%
Une question, une configuration particulière ?
Contactez-nous pour un devis.